Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation

NCT: NCT04818502 · ACTIVE_NOT_RECRUITING

NCT IDNCT04818502
StatusACTIVE_NOT_RECRUITING
Start Date2021-05-04
Completion2028-05-31

Brief Summary

To evaluate the safety and performance of the Tendyne™ Mitral Valve System when used as intended in a contemporary, real-world setting.

Frequently Asked Questions

What is Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation?

Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation is a clinical trial registered under NCT04818502. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04818502?

The current status of NCT04818502 (Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation) is: ACTIVE_NOT_RECRUITING.

When did Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation start?

Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation started on 2021-05-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑